Rafael Amado
2018 - Adaptimmune Therapeutics
Compensation breakdown
| Non-Equity Incentive Plan | $198,879 |
|---|---|
| Option Awards | $1,891,059 |
| Salary | $467,952 |
| Other | $43,306 |
| Total | $2,601,196 |
Amado received $1.9M in option awards, accounting for 73% of the total pay in 2018.
Amado also received $198.9K in non-equity incentive plan, $468K in salary and $43.3K in other compensation.
Rankings
In 2018, Rafael Amado's compensation ranked 4,494th out of 14,244 executives tracked by ExecPay. In other words, Amado earned more than 68.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,494 out of 14,244 | 68th |
Division Manufacturing | 1,684 out of 5,765 | 71st |
Major group Chemicals And Allied Products | 606 out of 2,128 | 72nd |
Industry group Drugs | 507 out of 1,817 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 98 out of 339 | 71st |
Pay ratio
| Rafael Amado's Pay | $2,601,196 |
|---|---|
| Median Employee's Pay | $137,800 |
| Pay Ratio | 19to 1 |
In 2018, the annual total compensation of Rafael Amado was $2,601,196.
The annual total compensation of the median employee at Adaptimmune Therapeutics was $137,800.
The ratio of Rafael Amado's pay to the pay of median employee was therefore 19 to one.
Amado's colleagues
We found four more compensation records of executives who worked with Rafael Amado at Adaptimmune Therapeutics in 2018.
News
April 26, 2022
April 22, 2021
April 23, 2020
March 15, 2019